
|Videos|February 17, 2022
Shift to Performance-Based Reimbursement Presents Opportunities for Pharmacies
Marci Strauss, PharmD, discussed how pharmacists are reacting to the ongoing shift toward performance-based reimbursement models.
Advertisement
In an interview at PDS 2022, Marci Strauss, PharmD, discussed how pharmacists are reacting to the ongoing shift toward performance-based reimbursement models.
Strauss discussed common challenges associated with reimbursement, the shift to a performance-based model, her work on the PDS program tackling performance-based reimbursement, and where she expects to see all of these issues heading in the future. Regardless of where reimbursement models go, Strauss said remaining ahead of the curve is essential for independent pharmacies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show
5








































































































































